Personalizing Therapy for the Treatment of Patients with Lung Cancer (audio)
The advancement of personalized medicine is changing the approach to lung cancer treatment and leading to more effective results.
In this podcast, Melissa Johnson, MD, explains the latest developments in targeted therapies and the advantages of multidisciplinary care. Dr. Johnson is joined by one of her patients, who shares how she has benefited from therapies tailored specifically to her tumor.
Melissa Johnson, MD, is a thoracic oncologist on the medical staff at Northwestern Memorial Hospital and an assistant professor of Medicine in the Division of Hematology/Oncology at Northwestern University Feinberg School of Medicine.